Assessment of myocardial viability by nuclear imaging techniques.
The assessment of myocardial viability has become important in the diagnostic and prognostic work up of patients with ischemic cardiomyopathy. Patients with viable myocardium may benefit from revascularization in terms of improvement of function, symptoms, and prognosis. In contrast, patients without viable myocardium do not benefit and should be treated conservatively. Various nuclear imaging techniques are available.
Bax
Jeroen J
JJ
Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. j.j.bax@lumc.nl
Poldermans
Don
D
Elhendy
Abdou
A
Boersma
Eric
E
van der Wall
Ernst E
EE
D000818:Animals; D009202:Cardiomyopathies / Q000000981:diagnostic imaging* / Q000601:surgery; D048909:Diabetes Complications; D004195:Disease Models, Animal; D025401:Echocardiography, Stress; D019788:Fluorodeoxyglucose F18; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D009200:Myocardial Contraction; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging*; D009204:Myocardial Revascularization; D017682:Myocardial Stunning; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013318:Stroke Volume; D013552:Swine; D015899:Tomography, Emission-Computed, Single-Photon; D018487:Ventricular Dysfunction, Left; D016277:Ventricular Function, Left / Q000502:physiology
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
Am J Cardiol. 1999 Jan 1;83(1):1-5
10073775
Curr Probl Cardiol. 2001 Feb;26(2):147-86
11276916
Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):314-21
15791441
Circulation. 1998 Nov 10;98 (19 Suppl):II51-6
9852880
Circulation. 1998 Aug 11;98(6):501-8
9714106
Circ Res. 2003 Dec 12;93(12 ):1146-58
14670830
Am Heart J. 1989 Jan;117(1):211-21
2783527
J Am Coll Cardiol. 2000 Sep;36(3):739-45
10987593
Am J Cardiol. 1995 Jun 15;75(17 ):1214-9
7778542
Eur J Cardiothorac Surg. 2002 Sep;22(3):426-30
12204735
J Am Coll Cardiol. 2004 Jul 7;44(1):1-9
15234396
Clin Cardiol. 2001 Jun;24(6):428-34
11403503
J Nucl Cardiol. 1994 Mar-Apr;1(2 Pt 2):S4-14
9420692
J Am Coll Cardiol. 1998 Oct;32(4):927-35
9768713
J Nucl Med. 1992 May;33(5):815-8
1533248
Circulation. 1997 Apr 1;95(7):1900-9
9107179
J Nucl Med. 1994 Jun;35(6):989-98
8195886
Heart. 2002 Aug;88(2):125-30
12117829
Circulation. 2004 Oct 19;110(16):2383-8
15477413
Prog Cardiovasc Dis. 2001 Mar-Apr;43(5):387-98
11251126
Curr Opin Hematol. 2004 Nov;11(6):399-403
15548994
Circulation. 1999 Jun 1;99(21):2798-805
10351975
Semin Nucl Med. 2000 Oct;30(4):281-98
11105929
J Nucl Med. 2003 Jun;44(6):877-83
12791813
Circulation. 1993 Jul;88(1):107-15
8319323
J Am Coll Cardiol. 2002 Apr 3;39(7):1151-8
11923039
Circulation. 2003 Nov 25;108(21):2596-603
14638522
J Nucl Cardiol. 2004 May-Jun;11(3):318-34
15173779
Eur Heart J. 1999 Mar;20(6):421-8
10213345
Circulation. 1993 May;87(5):1513-23
8491006
Am J Cardiol. 1992 Apr 1;69(9):854-9
1550012
Circulation. 1998 Jan 27;97(3):282-9
9462531
J Nucl Med. 2001 Jan;42(1):79-86
11197985
Circulation. 1994 Dec;90(6):2687-94
7994809
Am J Cardiol. 2000 Mar 15;85(6):680-4
12000040
Am J Physiol. 1999 Feb;276(2 Pt 2):H446-55
9950844
Heart. 2004 Aug;90 Suppl 5:v26-33
15254006
Am J Cardiol. 2002 Nov 18;90(10A):65J-71J
12450593